Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
Yuren WangHua QuXin XiongYuyang QiuYong LiaoYing-Chun ChenYi ZhengHongting ZhengPublished in: Mediators of inflammation (2018)
Circulating asprosin might be a predictor of early diagnosis in DM and might be a potential therapeutic target for prediabetes and T2DM.